Skip navigation
Restiffic - Drug Free Treatment for RLS

medi UK announce the national release of Restiffic® compressive foot wrap for the treatment of Restless Legs Syndrome (RLS). Restiffic offers a unique and drug-free therapy for patients suffering from RLS and can be purchased online at www.restiffic.co.uk

“RLS is a debilitating condition for an estimated 10% of the UK population, with many suffering from depression due to fatigue and quality of life issues,” said Ian Grant, Director of medi UK. “The inability to sleep affects every aspect of their lives, as well as the lives of their close family”.

Restiffic offers innovative, drug-free therapy for RLS by applying pressure to targeted muscles in the foot, which in turn relaxes the muscles to lessen the symptoms of RLS.
“RLS is traditionally treated with powerful pharmaceuticals which may help to some degree but the problems encountered by the medications are often of equal or greater significance than the RLS,” said Dr John Sullivan, a neurologist based in Florida who was involved in Restiffic’s clinical trial.

The highlights of the Restiffic clinical trial include:
• Over 95% of patients had significant reduction in RLS symptoms
• Shown to be 40% more effective than the leading pharmaceutical treatment for RLS
• Patients experienced a 69% reduction in RLS symptoms after 6 weeks of device usage

Restiffic is available for purchase at www.restiffic.co.uk

About medi UK - medi is the global leader in innovative products and holistic concepts with the very latest technologies. Our product spectrum ranges from medical compression garments for prophylaxis and treating oedema and veins and orthopaedic soft supports through to braces.

Contact - medi UK Ltd., Plough Lane, Hereford, HR4 0EL, Herefordshire. Tel. 01432 373500. restiffic@mediuk.co.uk
www.mediuk.co.uk
www.restiffic.co.uk

This press release was distributed by ResponseSource Press Release Wire on behalf of Medi UK in the following categories: Health, Consumer Technology, Medical & Pharmaceutical, for more information visit http://pressreleasewire.responsesource.com/about.